-
1
Inhibiting the alternative pathway of complement by reducing systemic complement factor B: Randomized, double-blind, placebo-controlled phase 1 studies with Sefaxersen
Published 2025-03-01Subjects: “…Complement Alternative Pathway…”
Get full text
Article -
2
Characterization of the bispecific VHH antibody tarperprumig (ALXN1820) specific for properdin and designed for low-volume administration
Published 2024-12-01Subjects: Get full text
Article